Stay updated with breaking news from Nasdaq rytm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $50.00 price target on the stock. Needham & Company LLC’s price target would suggest a potential upside […] ....
Needham & Company LLC reiterated their buy rating on shares of Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $50.00 target price on the stock. A number of other equities analysts also recently commented on RYTM. The Goldman Sachs Group upped their target […] ....
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its target price lowered by Wells Fargo & Company from $53.00 to $52.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other equities analysts have also recently weighed in on the stock. Needham & Company […] ....
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report)’s share price was down 4.4% on Thursday . The stock traded as low as $43.43 and last traded at $46.68. Approximately 90,505 shares were traded during mid-day trading, a decline of 87% from the average daily volume of 686,012 shares. The stock had previously closed at $48.81. […] ....
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) traded down 4.4% during trading on Thursday . The stock traded as low as $43.43 and last traded at $46.68. 90,505 shares traded hands during trading, a decline of 87% from the average session volume of 686,012 shares. The stock had previously closed at $48.81. Analyst Upgrades […] ....